Biocon is a biopharmaceutical company based in Bangalore.
Founded in 1978, Biocon manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics, as well as, biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Biocon's formulations for the Indian market include Metabolics, Oncology, Immunotherapy, Nephrology and Specialty. Biocon's discovery-led R&D focuses on the entire drug development pathway - from process development, to non-clinical and clinical research.